• Jul 10, 2012: Recent presentations available for download
  
  Matrix Independent Quantification of Proteins to Attomole Levels in Milligram-sized Samples presented at ASMS 2012.
  
  Quantitative Analysis of Proteins by Accelerator Mass Spectrometry presented at DVDMDG April 2012.
  
• Aug 31, 2011: The journal Bioanalysis announces the best of Bioanalysis 2010
  
  Senior Editors of the journal Bioanalysis, published by Future Science, Dr Brian P Booth (US FDA), Dr Howard Hill (Huntingdon Life Sciences) and the editorial advisory panel announced the selection of the Review article by Stephen Dueker, (Vitalea Science Chief Scientific Officer), et al as the Best of Bioanalysis 2010. The decision was based on the potential impact that emerging concepts will have on reducing timelines of the drug development process.
  
  The article was entitled Early human ADME using microdoses and microtracers: bioanalytical considerations.
  
  
• Jun 17, 2011: Vitalea's Dr. John Vogel and Dr. Stephen Dueker at ASMS 2011
  
  John Vogel, Scientific Advisor to Vitalea and Stephen Dueker, Company Founder and CSO discussed with colleagues novel concepts in technology and applied accelerator mass spectrometry and their effects on the efficiencies of analytical analyses. The posters are available for download: Absolute Measurement of Carbon Isotope Ratios with Accelerator Mass Spectrometry and Isotope Ratio Accelerator Mass Spectometry Method Validation: Single-Point Calibration and "Zero" Drug LLOQs.
  
  
  
  
• Mar 14, 2011: Vitalea Science, Inc. Appoints Jim Settlage as Laboratory Director
  
  Vitalea Science, Inc., a leading provider of pharmaceutical development solutions is proud to announce the appointment of Jim Settlage, Ph.D. as Laboratory Director. The appointment is effective immediately. Since receiving his Ph.D. from University of California , Davis, Dr. Settlage has focused his career within contract research organizations (CROs), contributing greatly to the maturity of the industry from its infancy over a span of 30 years. ...read more
  
  
  
  
• Jan 20, 2011: Vitalea Appoints Robert A. Bethem as President & Chief Executive Officer
  
  Vitalea Science, Inc and its board of directors are proud to announce the appointment of Robert A. Bethem as President and Chief Executive Officer. Bethem succeeds founder and former CEO Stephen Dueker, who will now take the position of Chief Scientific Officer ...read more
  
  
  
  
  
  
• Dec 17, 2010: Dr. Stephen Dueker at CPSA 2009
  
  At the 12th Annual CPSA symposium "From Data to Biology: Analytical Measurements to Drive Pharmaceutical R&D," Dr. Dueker informs an audience of pharmaceutical scientists on the advantages of applied AMS as a tool for better understanding of the behavior of your compound.